GoodRx Holdings, Inc. (GDRX) Misses Q3 EPS by 14c; Guides Lower

GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q3 EPS of ($0.10), $0.14 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $187.3 million versus the consensus estimate of $185.01 million.

GUIDANCE:

GoodRx Holdings, Inc. sees Q4 2022 revenue of $173-180 million, versus the consensus of $204.24 million.

For earnings history and earnings-related data on GoodRx Holdings, Inc. (GDRX) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
• L3Harris CEO steps down amid conduct review, shares drop